aTyr Pharma | LIFE - Zysk Brutto Na Sprzedaży





Zysk Brutto Na Sprzedaży Zmiana Data
Ardelyx USD 114.37M 8.02M 2025-12
aTyr Pharma USD 190K 15.57M 2025-09
Biogen USD 1.82B 169.5M 2026-03
Bristol-Myers Squibb USD 8.41B 381M 2025-12
Cipla INR 39.1B 2.54B 2026-03
Clal Biotechnology ILS -857K 1.42M 2022-06
Compugen USD 63.8M 63.56M 2025-12
CSL USD 4.46B 2.71B 2025-12
Curis USD 1.14M 8.86M 2025-12
GlaxoSmithKline GBP 5.75B 429M 2026-03
Grifols EUR 766.49M 39.74M 2024-12
Lakefront Biotherapeutics EUR 1.68M 898.68M 2026-03
Novartis USD 10.07B 184M 2026-03
Roche Holding CHF 22.09B 10.04B 2025-12
United Therapeutics USD 315.5M 286.6M 2025-12
Xoma 992K 846K 2024-06